Nektar Therapeutics (NKTR) - Get in under right conditions
Company info:
Nektar Therapeutics is a biopharmaceutical company, focused on the development of treatments utilizing its PEGylation and advanced polymer conjugate technology platforms. Nektar primarily finances its operations with funds from licensing, collaboration and manufacturing agreements. It has collaboration deals with companies namely AstraZeneca, Pfizer, Roche, Amgen, Bristol-Myers and Eli Lilly among others.
This stock has been beaten down but has large institutional buys in it so make it suspectable to high downside volatility, be careful. Volatility can act both ways!
Looking for a RS or J Hook to get in.
Target would be around 0.99 and will decide then if to hold or sell or take profits off and let it run. (if it goes there of course!)
Nektar Therapeutics is a biopharmaceutical company, focused on the development of treatments utilizing its PEGylation and advanced polymer conjugate technology platforms. Nektar primarily finances its operations with funds from licensing, collaboration and manufacturing agreements. It has collaboration deals with companies namely AstraZeneca, Pfizer, Roche, Amgen, Bristol-Myers and Eli Lilly among others.
This stock has been beaten down but has large institutional buys in it so make it suspectable to high downside volatility, be careful. Volatility can act both ways!
Looking for a RS or J Hook to get in.
Target would be around 0.99 and will decide then if to hold or sell or take profits off and let it run. (if it goes there of course!)